Victoria L. Hewitt

Victoria L. Hewitt

Auto-generated profile, based on publicly available information

Victoria L. Hewitt

MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0XY, UK

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2015 in Science
Verified
Journal Article
Closed access
PDF file
TSTakuya Shiota
Takuya Shiota
KIKenichiro Imai
Kenichiro Imai
JQJian Qiu
Jian Qiu
VHVictoria L. Hewitt
Victoria L. Hewitt
KTKhershing Tan
Khershing Tan
TEToshiya Endo
Toshiya Endo
Dissecting the mitochondrial entry portal: Mitochondria, the powerhouses of the cell, are mainly composed of proteins made in the cytosol. These newly synthesized proteins need to be imported across the organelle's membrane through dedicated protein import machinery. Shiota et al. have worked out the architecture and mechanism of the mitochondrial protein import channel. Science , this issue p. 1544

18 March 2022 in Science
Verified
Journal Article
Closed access
JOJustin K. O’hare
Justin K. O’hare
KGKevin C. Gonzalez
Kevin C. Gonzalez
SHStephanie A. Herrlinger
Stephanie A. Herrlinger
YHYusuke Hirabayashi
Yusuke Hirabayashi
VHVictoria L. Hewitt
Victoria L. Hewitt
ALAttila Losonczy
Attila Losonczy
Dendritic calcium signaling is central to neural plasticity mechanisms that allow animals to adapt to the environment. Intracellular calcium release (ICR) from the endoplasmic reticulum has long been thought to shape these mechanisms. However, ICR has not been investigated in mammalian neurons in vivo. We combined electroporation of single CA1 pyramidal neurons, simultaneous imaging of dendritic and somatic activity during spatial navigation, optogenetic place field induction, and acute genetic augmentation of ICR cytosolic impact to reveal that ICR supports the establishment of dendritic feature selectivity and shapes integrative properties determining output-level receptive fields. This role for ICR was more prominent in apical than in basal dendrites. Thus, ICR cooperates with circuit-level architecture in vivo to promote the emergence of behaviorally relevant plasticity in a compartment-specific manner.

15 November 2019 in Neurobiology of Disease
Verified
Journal Article
Open access
ALAndrea Loreto
Andrea Loreto
CHCiaran S. Hill
Ciaran S. Hill
VHVictoria L. Hewitt
Victoria L. Hewitt
Giuseppe OrsomandoGiuseppe Orsomando
Giuseppe Orsomando
CACarlo Angeletti
Carlo Angeletti
MCMichael P. Coleman
Michael P. Coleman
Wallerian degeneration of physically injured axons involves a well-defined molecular pathway linking loss of axonal survival factor NMNAT2 to activation of pro-degenerative protein SARM1. Manipulating the pathway through these proteins led to the identification of non-axotomy insults causing axon degeneration by a Wallerian-like mechanism, including several involving mitochondrial impairment. Mitochondrial dysfunction is heavily implicated in Parkinson's disease, Charcot-Marie-Tooth disease, hereditary spastic paraplegia and other axonal disorders. However, whether and how mitochondrial impairment activates Wallerian degeneration has remained unclear. Here, we show that disruption of mitochondrial membrane potential leads to axonal NMNAT2 depletion in mouse sympathetic neurons, increasing the substrate-to-product ratio (NMN/NAD) of this NAD-synthesising enzyme, a metabolic fingerprint of Wallerian degeneration. The mechanism appears to involve both impaired NMNAT2 synthesis and reduced axonal transport. Expression of WLDS and Sarm1 deletion both protect axons after mitochondrial uncoupling. Blocking the pathway also confers neuroprotection and increases the lifespan of flies with Pink1 loss-of-function mutation, which causes severe mitochondrial defects. These data indicate that mitochondrial impairment replicates all the major steps of Wallerian degeneration, placing it upstream of NMNAT2 loss, with the potential to contribute to axon pathology in mitochondrial disorders.

7 April 2016 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
KBKatie R. Baldwin
Katie R. Baldwin
VGVinay K. Godena
Vinay K. Godena
VHVictoria L. Hewitt
Victoria L. Hewitt
AWAlexander Whitworth
Alexander Whitworth
Amyotrophic lateral sclerosis (ALS) is characterized by the degeneration of motor neurons resulting in a catastrophic loss of motor function. Current therapies are severely limited owing to a poor mechanistic understanding of the pathobiology. Mutations in a large number of genes have now been linked to ALS, including SOD1, TARDBP (TDP-43), FUS and C9orf72. Functional analyses of these genes and their pathogenic mutations have provided great insights into the underlying disease mechanisms. Defective axonal transport is hypothesized to be a key factor in the selective vulnerability of motor nerves due to their extraordinary length and evidence that ALS occurs as a distal axonopathy. Axonal transport is seen as an early pathogenic event that precedes cell loss and clinical symptoms and so represents an upstream mechanism for therapeutic targeting. Studies have begun to describe the impact of a few pathogenic mutations on axonal transport but a broad survey across a range of models and cargos is warranted. Here, we assessed the axonal transport of different cargos in multiple Drosophila models of ALS. We found that axonal transport defects are common across all models tested, although they often showed a differential effect between mitochondria and vesicle cargos. Motor deficits were also common across the models and generally worsened with age, though surprisingly there was not a clear correlation between the severity of axonal transport defects and motor ability. These results further support defects in axonal transport as a common factor in models of ALS that may contribute to the pathogenic process.

1 April 2012 in Eukaryotic Cell
Verified
Journal Article
Closed access
PDF file
YQYue Qu
Yue Qu
BJBranka Jelicic
Branka Jelicic
FPFilomena Pettolino
Filomena Pettolino
APAndrew Perry
Andrew Perry
TLTricia L. Lo
Tricia L. Lo
ATAna Traven
Ana Traven
Recent studies indicate that mitochondrial functions impinge on cell wall integrity, drug tolerance, and virulence of human fungal pathogens. However, the mechanistic aspects of these processes are poorly understood. We focused on the mitochondrial outer membrane SAM ( S orting and A ssembly M achinery) complex subunit Sam37 in Candida albicans . Inactivation of SAM37 in C. albicans leads to a large reduction in fitness, a phenotype not conserved with the model yeast Saccharomyces cerevisiae . Our data indicate that slow growth of the sam37ΔΔ mutant results from mitochondrial DNA loss, a new function for Sam37 in C. albicans , and from reduced activity of the essential SAM complex subunit Sam35. The sam37ΔΔ mutant was hypersensitive to drugs that target the cell wall and displayed altered cell wall structure, supporting a role for Sam37 in cell wall integrity in C. albicans . The sensitivity of the mutant to membrane-targeting antifungals was not significantly altered. The sam37ΔΔ mutant was avirulent in the mouse model, and bioinformatics showed that the fungal Sam37 proteins are distant from their animal counterparts and could thus represent potential drug targets. Our study provides the first direct evidence for a link between mitochondrial function and cell wall integrity in C. albicans and is further relevant for understanding mitochondrial function in fitness, antifungal drug tolerance, and virulence of this major pathogen. Beyond the relevance to fungal pathogenesis, this work also provides new insight into the mitochondrial and cellular roles of the SAM complex in fungi.

1 March 2011 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
VHVictoria Hewitt
Victoria Hewitt
FAFelicity Alcock
Felicity Alcock
TLTrevor Lithgow
Trevor Lithgow